FDA Risk-Based CMC Review Should Include List Of High-Risk Drugs - PhRMA
Executive Summary
FDA's risk-based chemistry, manufacturing & controls review proposal should include a list of high-risk drugs, Pharmaceutical Research & Manufacturers of America said.